Section Arrow
CSTL.NASDAQ
- Castle Biosciences
Quotes are at least 15-min delayed:2026/02/12 08:11 EST
Pre Market
Last
 --
-- (--)
Bid
29.75
Ask
46
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 32.34
-0.03 (-0.09%)
Day High 
32.98 
Prev. Close
32.37 
1-M High
44.28 
Volume 
531.72K 
Bid
29.75
Ask
46
Day Low
31.38 
Open
32.62 
1-M Low
31.635 
Market Cap 
944.84M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 36.12 
20-SMA 38.72 
50-SMA 39.07 
52-W High 44.28 
52-W Low 14.59 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.44/-0.70
Enterprise Value
969.24M
Balance Sheet
Book Value Per Share
16.00
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
332.07M
Operating Revenue Per Share
6.58
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IQVIQVIA Holdings177.18-5.27-2.89%24.37PE
Pre Market 163.9 -13.28 -7.50%
DHRDanaher Corp219.98+0.23+0.10%45.39PE
Pre Market 219.61 -0.37 -0.17%
WATWaters Corp329.2+2.18+0.67%30.26PE
Pre Market 331.555 +2.355 +0.72%
NEOGNeogen Corp10.75+0.02+0.19%-- 
Pre Market 10.66 -0.09 -0.84%
ICLRICON plc133.14-11.41-7.89%17.94PE
Pre Market 95.74 -37.4 -28.09%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.